A steroid‑induced osteonecrosis model established using an organ‑on‑a‑chip platform
Tengqi Li, Yadi Liu, Qingyu Zhang, Wei Sun, Yiyang Dong
Journal:Experimental and Therapeutic Medicine
IF:2.45
DOI:10.3892/etm.2021.10504
PMID:34447463
Published:2021-07-28
research field:分子生物学细胞生物学心血管疾病
Abstract
Bone microvascular endothelial cells (BMECs) constitute the central part of the femoral head's intramural microenvironment network and have an essential role in the development of steroid‑induced osteonecrosis of the femoral head. Recently, the rapid development of microfluidic technology has led to innovations in the fields of chemistry, medicine and life sciences. It is now possible to use microfluidics organ‑on‑a‑chip techniques to assess osteonecrosis. In the present study, BMECs were cultured on a microfluidic organ‑on‑a‑chip platform to explore the pathogenesis of femoral‑head necrosis. The aim of the present study was to explore the effects of different interventions on BMECs and study the pathogenesis of steroid‑induced osteonecrosis through a microfluidic organ‑on‑a‑chip platform. Methods including SU‑8 lithography were used to produce a microfluidic organ‑on‑a‑chip and human umbilical vein endothelial cells (HUVECs) were used to test whether it was possible to culture cells on the chip. Subsequently, a set of methods were applied for the isolation, purification, culture and identification of BMECs. Hydroxyapatite (HA) was used for co‑culture, dexamethasone was used at different concentrations as an intervention in the cells and icariin was used for protection. BMECs were isolated and cultured from the femoral head obtained following total hip arthroplasty and were then inoculated into the microfluidic organ‑on‑a‑chip for further treatment. In part I of the experiment, HUVECs and BMECs both successfully survived on the chip and a comparison of the growth and morphology was performed. HA and BMECs were then co‑cultured for comparison with the control group. The cell growth was observed by confocal microscopy after 24 h. In part II, the effects of different concentrations of glucocorticoid (0.4 or 0.6 mg/ml dexamethasone) and the protection of icariin were eval
本文使用的Yeasen产品


